|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash lease expense | |||||
| Credit loss expense (recovery) | |||||
| Stock-based compensation | |||||
| Deferred taxes, net | |||||
| Unrealized foreign exchange (gains) losses | |||||
| Net realized (gains) losses on marketable debt securities, available-for-sale | |||||
| Other non-cash items | |||||
| Changes in operating assets and liabilities: | |||||
| Commissions receivable | |||||
| Prepaid expenses | |||||
| Advances and loans | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Income tax receivable and payable | |||||
| Accrued bonuses and other employee related expenses | |||||
| Deferred compensation and commissions | |||||
| Operating lease liabilities | |||||
| Other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Acquisition of businesses, net of cash received | |||||
| Purchases of marketable debt securities, available-for-sale | |||||
| Proceeds from sales and maturities of marketable debt securities, available-for-sale | |||||
| Purchases of convertible notes | |||||
| Purchases of securities, held-to-maturity | |||||
| Issuances of employee notes receivable | |||||
| Payments received on employee notes receivable | |||||
| Purchase of property and equipment | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Taxes paid related to net share settlement of stock-based awards | |||||
| Proceeds from issuance of shares pursuant to employee stock purchase plan | |||||
| Dividends paid | |||||
| Principal payments on stock appreciation rights liability | |||||
| Principal payments on deferred and contingent consideration | |||||
| Cash paid for stock repurchases | |||||
| Net cash used in financing activities | |||||
| Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest paid during the period | |||||
| Income taxes paid, net | |||||
| Cash paid for amounts included in the measurement of operating lease liabilities | |||||
| Supplemental disclosures of noncash investing and financing activities: | |||||
| Unpaid purchases of property and equipment | |||||
| Right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Issuance of stock for the settlement of deferred consideration | |||||
| Dividend payable | |||||
Loading...